Market Research Report Global Biosimilar Pipeline Market Report | Page 3

Global biosimilar clinical trials in 2017
 What was the volume of biosimilar clinical trials from 2006 to 2016, by
therapy area and stage of development?
 What is the average biosimilar clinical trial size and duration across different
stages of development, and across the immunology and oncology therapy
areas?
 How much revenue will promising biosimilar drugs in the market, and in
development, record to 2022?
 What are the key factors driving growth in the global biosimilars market?
 How important are the cost saving opportunities for national healthcare
budgets?
 How much will biosimilar manufacturer’s benefit from the biologic drugs
patent cliff?
 How does legislation regarding biosimilar interchangeability differ among
key geographical markets?
 What are the factors restraining the growth of global biosimilar market?
 How do manufacturing challenges affect the market?
 What are the legal issues impacting the biosimilar market?
 How are competition and patient recruitment issues slowing growth in the
market?
 What are the regulatory pathways for biosimilars in the US, Europe, Japan
and China?
 Manufacturing processes for biosimilar drugs
 How does molecular weight and complexity pose a challenge to biosimilar
production?
 What is the impact of environmental factors on production complexity?
 How significant is the knowledge gap in the process of manufacturing a
bios